Ramon Bosch-Príncep

8PUBLICATIONS
38CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Formal methods for software
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 04, 2026
Longitudinal evaluation of tumor-infiltrating lymphocyte scoring using automated region of interest registration in breast cancer.

|Jul 29, 2023
Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.

Marylène Lejeune, Laia Reverté, Noèlia Gallardo

|Feb 11, 2023
Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response.

Marylène Lejeune, Laia Reverté, Esther Sauras

|Oct 14, 2022
Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn's Disease.

Albert Boronat-Toscano, Diandra Monfort-Ferré, Margarita Menacho

|Apr 23, 2022
DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals-Planification, Implementation, and Preliminary Results.

Jordi Temprana-Salvador, Pablo López-García, Josep Castellví Vives

|Aug 12, 2021
How the variability between computer-assisted analysis procedures evaluating immune markers can influence patients' outcome prediction.

Marylène Lejeune, Benoît Plancoulaine, Nicolas Elie

Pageof 2

Frequent Collaborators

6 joint publications

Marylène Lejeune

3 joint publications

Carlos López-Pablo

3 joint publications

Noèlia Gallardo-Borràs

3 joint publications

Anna Korzyńska